[go: up one dir, main page]

LU90245B1 - Pilules de fluox-tine ent-riques - Google Patents

Pilules de fluox-tine ent-riques

Info

Publication number
LU90245B1
LU90245B1 LU90245A LU90245A LU90245B1 LU 90245 B1 LU90245 B1 LU 90245B1 LU 90245 A LU90245 A LU 90245A LU 90245 A LU90245 A LU 90245A LU 90245 B1 LU90245 B1 LU 90245B1
Authority
LU
Luxembourg
Prior art keywords
fluoxine
enteric
pills
fluoxine pills
enteric fluoxine
Prior art date
Application number
LU90245A
Other languages
English (en)
Other versions
LU90245A1 (fr
Inventor
Neil Robert Anderson
Roger Garrick Harrison
Daniel Frederick Lynch
Peter Lloyd Oren
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25349313&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU90245(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of LU90245A1 publication Critical patent/LU90245A1/fr
Application granted granted Critical
Publication of LU90245B1 publication Critical patent/LU90245B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
LU90245A 1997-05-29 1998-05-20 Pilules de fluox-tine ent-riques LU90245B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/867,196 US5910319A (en) 1997-05-29 1997-05-29 Fluoxetine enteric pellets and methods for their preparation and use

Publications (2)

Publication Number Publication Date
LU90245A1 LU90245A1 (fr) 1998-11-30
LU90245B1 true LU90245B1 (fr) 2002-07-31

Family

ID=25349313

Family Applications (1)

Application Number Title Priority Date Filing Date
LU90245A LU90245B1 (fr) 1997-05-29 1998-05-20 Pilules de fluox-tine ent-riques

Country Status (45)

Country Link
US (3) US5910319A (fr)
JP (1) JP3210288B2 (fr)
KR (1) KR100549473B1 (fr)
CN (2) CN1161109C (fr)
AR (1) AR011728A1 (fr)
AT (1) AT408068B (fr)
AU (1) AU726690B2 (fr)
BE (1) BE1011925A3 (fr)
BR (1) BR9801989A (fr)
CA (1) CA2234826C (fr)
CH (1) CH693018A5 (fr)
CO (1) CO4940407A1 (fr)
CZ (1) CZ290582B6 (fr)
DE (1) DE19823940B4 (fr)
DK (1) DK176776B1 (fr)
ES (1) ES2161574B1 (fr)
FI (1) FI119971B (fr)
FR (1) FR2763846B1 (fr)
GB (1) GB2325623B (fr)
GR (1) GR980100188A (fr)
HU (1) HUP9800882A3 (fr)
ID (1) ID20343A (fr)
IL (1) IL124073A (fr)
IT (1) ITMI980908A1 (fr)
LT (1) LT4477B (fr)
LU (1) LU90245B1 (fr)
LV (1) LV12176B (fr)
MY (1) MY118139A (fr)
NL (1) NL1009259C2 (fr)
NO (1) NO317743B1 (fr)
NZ (1) NZ330192A (fr)
PE (1) PE75399A1 (fr)
PL (1) PL192293B1 (fr)
PT (1) PT102152B (fr)
RO (1) RO120043B1 (fr)
RS (1) RS49827B (fr)
RU (1) RU2164405C2 (fr)
SE (1) SE522914C2 (fr)
SG (1) SG72805A1 (fr)
SI (1) SI9800128B (fr)
SV (1) SV1998000052A (fr)
TR (1) TR199800937A2 (fr)
TW (1) TWI239838B (fr)
UA (1) UA48193C2 (fr)
ZA (1) ZA983173B (fr)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2752732B1 (fr) * 1996-08-28 1998-11-20 Pf Medicament Forme galenique a liberation prolongee de milnacipran
IE990406A1 (en) 1999-05-20 2000-12-27 Elan Corp Plc Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
CA2374039C (fr) * 1999-05-20 2011-01-11 Elan Corporation Plc Preparations d'inhibiteurs specifiques du recaptage de la serotonine a liberation multiparticulaire regulee
ES2162560B1 (es) * 1999-06-25 2002-07-16 Rodriguez Concepcion Pena Uso de fluoxetina, paroxetina y otros isrs para la fabricacion de medicamentos con el fin de aumentar la capacidad de abstenerse de substancias o actividades que crean dependencia.
DK1225881T3 (da) 1999-09-03 2006-06-12 Apbi Holdings Llc Anvendelsen af dapoxetin, en hurtigt-virkende selektiv serotonin genoptagelseshæmmer, til behandling af seksuel dysfunktion
CN1094347C (zh) * 1999-11-15 2002-11-20 广东药学院药物研究所 一种治疗前列腺良性增生症的控释微丸及其制备方法
US6273260B1 (en) 2000-03-08 2001-08-14 Eli Lilly And Company Pharmaceutical packaging system
ES2185452B2 (es) * 2000-08-01 2004-03-16 Cinfa S A Lab Composicion farmaceutica de fluoxetina en comprimido dispersable recubierto y su proceso de fabricacion.
JP4181738B2 (ja) * 2000-08-25 2008-11-19 信越化学工業株式会社 腸溶性コーティング製剤の製造方法
US6482440B2 (en) * 2000-09-21 2002-11-19 Phase 2 Discovery, Inc. Long acting antidepressant microparticles
WO2002038126A2 (fr) * 2000-11-08 2002-05-16 Aeromatic-Fielder Ag Procede de production de particules pour preparations pharmaceutiques presentant une biodisponibilite accrue
US20040170688A1 (en) * 2001-08-06 2004-09-02 Deshmukh Abhijit Mukund Enteric formulation of fluoxetin
CA2457385A1 (fr) 2001-08-06 2003-02-20 Dr. Reddy's Laboratories Ltd. Preparation enterique de fluoxetine
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
AU2002361495A1 (en) * 2002-12-24 2004-07-22 Lupin Limited Enteric coated fluoxetine composition
US8614247B2 (en) * 2003-04-10 2013-12-24 Institut National De La Sante Et De La Recherche Medicale Methods for preventing, attenuating or treating pulmonary hypertension using a serotonin transporter inhibitor, and pharmaceutical compositions for the treatment thereof
CA2526730A1 (fr) 2003-05-30 2004-12-09 Ranbaxy Laboratories Limited Derives pyrroliques substitues
US20050176693A1 (en) * 2003-08-12 2005-08-11 Boissonneault Roger M. Method of intermittent administration of a pharmaceutical for the treatment of conditions associated with a female's menstrual cycle
WO2005065726A1 (fr) * 2003-12-30 2005-07-21 Dr. Reddy's Laboratories Ltd. Composition pharmaceutique
CA2579767A1 (fr) * 2004-04-30 2005-11-10 Astellas Pharma Inc. Composition pharmaceutique orale sous forme particulaire a liberation chronocontrolee et comprimes a dissolution rapide ainsi constitues
KR100920856B1 (ko) * 2004-11-30 2009-10-09 (주)아모레퍼시픽 선택적 세로토닌 재흡수 억제제의 연장방출 제제 및 그제조방법
JP2007523213A (ja) * 2004-12-23 2007-08-16 テバ ファーマシューティカル インダストリーズ リミティド 医薬的に許容できるデュロキセチンの塩及びその中間体の調製方法
JP5153629B2 (ja) * 2005-08-02 2013-02-27 ルピン・リミテッド 選択的セロトニン再取り込み阻害剤の新規の制御放出組成物
JP2009514851A (ja) 2005-11-08 2009-04-09 ランバクシー ラボラトリーズ リミテッド （３ｒ，５ｒ）−７−［２−（４−フルオロフェニル）−５−イソプロピル−３−フェニル−４−［（４−ヒドロキシメチルフェニルアミノ）カルボニル］−ピロール−１−イル］−３，５−ジヒドロキシ−ヘプタン酸ヘミカルシウム塩の製法
WO2007062119A1 (fr) * 2005-11-23 2007-05-31 Auspex Pharmaceuticals, Inc. Aryloxypropylamines substituées possédant une activité sérotoninergique et/ou norépinephrinergique
WO2007067581A1 (fr) * 2005-12-05 2007-06-14 Teva Pharmaceutical Industries Ltd. 2-(n-methyl-propanamine)-3-(2-naphtol)thiophene, une impurete du duloxetine chlorhydrate
US20080033030A1 (en) * 2006-02-24 2008-02-07 Capua Simona D Fluvastatin sodium pharmaceutical compositions
CN101057837B (zh) * 2006-04-20 2010-12-22 湖南九典制药有限公司 一种右旋酮洛芬肠溶微丸及制备方法
EP2016066A4 (fr) * 2006-05-10 2010-11-24 Reddys Lab Ltd Dr Procédé de préparation de duloxétine
JP2009538315A (ja) * 2006-05-22 2009-11-05 テバ ファーマシューティカル インダストリーズ リミティド 塩酸デュロキセチン遅延放出型製剤
US20100297226A1 (en) * 2006-06-01 2010-11-25 Dexcel Pharma Technologies Ltd. Multiple unit pharmaceutical formulation
JP5052051B2 (ja) * 2006-06-16 2012-10-17 トーアエイヨー株式会社 腸溶性顆粒剤及びその製造方法
US20090252787A1 (en) * 2006-07-28 2009-10-08 Dr. Reddy's Laboratories Ltd. Granular pharmaceutical compositions
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
WO2008020286A2 (fr) * 2006-08-14 2008-02-21 Torrent Pharmaceuticals Limited Compositions pharmaceutiques de duloxétine
CA2664421A1 (fr) * 2006-09-22 2008-03-27 Braincells, Inc. Modulation induite par hmg coa reductase de la neurogenese
US20080226711A1 (en) * 2007-03-12 2008-09-18 Torrent Pharmaceuticals Ltd. Pharmaceutical compositions of duloxetine
US20090226517A1 (en) * 2008-02-06 2009-09-10 Vinita Umashankar Vyas Pharmaceutical formulations comprising duloxetine
MY156288A (en) 2008-07-16 2016-01-29 Richter Gedeon Nyrt Pharmaceutical formulations containing dopamine receptor ligands.
WO2010026993A1 (fr) * 2008-09-03 2010-03-11 武田薬品工業株式会社 Procédé pour améliorer la capacité d'une préparation à être absorbée et préparation dont la capacité à être absorbée est améliorée
CN101804145B (zh) * 2009-02-12 2012-11-14 杭州赛利药物研究所有限公司 一种大蒜油肠溶微丸胶囊及其制备方法
JP2013504562A (ja) * 2009-09-17 2013-02-07 カディラ・ヘルスケア・リミテッド アルコールで誘発される用量ダンピングを低減するための医薬組成物
JP5749247B2 (ja) * 2010-02-22 2015-07-15 第一三共株式会社 経口用徐放性固形製剤
RU2442572C1 (ru) * 2010-12-23 2012-02-20 Ольга Львовна Титова Энтеросолюбильная оболочка и композиция для ее получения
CA2870134C (fr) * 2012-05-02 2020-04-28 Capsugel France SAS Dispersions aqueuses d'acetate et succinate d'hydroxypropylmethylcellulose (hpmcas)
CN102716084B (zh) * 2012-06-29 2013-09-25 海南美大制药有限公司 盐酸氟西汀脂质体固体制剂
JP6129184B2 (ja) 2012-09-03 2017-05-17 第一三共株式会社 ヒドロモルフォン塩酸塩含有の経口用徐放性医薬組成物
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
KR20170005833A (ko) 2014-05-20 2017-01-16 다우 글로벌 테크놀로지스 엘엘씨 부분적으로 중화된 에스테르화 셀룰로오스 에테르를 포함하는 분산물
WO2015179073A1 (fr) * 2014-05-20 2015-11-26 Dow Global Technologies Llc Enveloppes de capsule comprenant un éther de cellulose estérifié
WO2015187874A1 (fr) * 2014-06-07 2015-12-10 Structure-Ase, Inc. Procédé de détection et/ou de diagnostic de troubles alimentaires et de malnutrition à l'aide de diffraction aux rayons x
US10471152B2 (en) 2014-08-29 2019-11-12 Capsugel Belgium Nv Colloidal dispersion comprising HPMCAS
EP3288556A4 (fr) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Compositions à désintégration par voie orale
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
US11274087B2 (en) 2016-07-08 2022-03-15 Richter Gedeon Nyrt. Industrial process for the preparation of cariprazine
EP3609578A4 (fr) * 2017-04-13 2021-03-10 Chase Therapeutics Corporation Combinaison pharmaceutique et son utilisation pour le traitement de synucléinopathies
HUP1700253A1 (hu) 2017-06-13 2019-01-28 Richter Gedeon Nyrt Szilárd orális gyógyszerkészítmények
CN107898942B (zh) * 2017-11-24 2021-01-26 一力制药(罗定)有限公司 一种感冒清热胶囊及其制备方法
US11547707B2 (en) 2019-04-10 2023-01-10 Richter Gedeon Nyrt. Carbamoyl cyclohexane derivatives for treating autism spectrum disorder
JP7606825B2 (ja) * 2020-06-15 2024-12-26 東和薬品株式会社 エソメプラゾール顆粒ならびにその製造方法および用途
WO2022115054A1 (fr) * 2020-11-27 2022-06-02 Santa Farma Ilac Sanayii A.S. Compositions de duloxétine à enrobage entérique

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4194009A (en) 1974-01-10 1980-03-18 Eli Lilly And Company Aryloxyphenylpropylamines for obtaining a psychotropic effect
US4018895A (en) 1974-01-10 1977-04-19 Eli Lilly And Company Aryloxyphenylpropylamines in treating depression
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
US4626549A (en) * 1974-01-10 1986-12-02 Eli Lilly And Company Treatment of obesity with aryloxyphenylpropylamines
JPS517116A (en) 1974-06-11 1976-01-21 Shinetsu Chemical Co Choyoseihifukuyakuzaino seizohoho
CH649216A5 (de) 1979-08-16 1985-05-15 Sandoz Ag Verfahren zur auftragung eines magensaftresistenten filmes auf einen heilmittelkern und feste einheitsdosierungsform mit magensaftresistentem film.
JPS5855125B2 (ja) * 1980-03-10 1983-12-08 信越化学工業株式会社 固形薬剤用腸溶性コ−テイング剤組成物
US4444778A (en) * 1981-08-27 1984-04-24 Coughlin Shaun R Method and composition for treating atherosclerosis
US4847092A (en) * 1985-11-12 1989-07-11 Eli Lilly And Company Orally administerable sustained release pharmaceutical formulations
US4797286A (en) 1985-11-12 1989-01-10 Eli Lilly And Company Orally administerable sustained release pharmaceutical formulations
GB2189699A (en) 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
US4918242A (en) 1988-03-30 1990-04-17 Aldrich Chemical Company, Inc. Novel optically 1,3-phenoxypropylhalides
CA1337955C (fr) * 1988-09-26 1996-01-23 Thomas A. Almquist Recouvrement de couches stereolithographiques
US4999382A (en) * 1988-10-26 1991-03-12 Massachusetts Institute Of Technology Compositions for treating tobacco withdrawal symptoms and methods for their use
US5356934A (en) * 1990-03-29 1994-10-18 Eli Lilly And Company Selected serotonin subtype receptor agonist to treat sleep apnea
US5589511A (en) * 1990-08-13 1996-12-31 Sepracor Inc. Method for treating migraine headaches using optically pure S(+) fluoxetine
US5104899A (en) * 1990-08-13 1992-04-14 Sepracor, Inc. Methods and compositions for treating depression using optically pure fluoxetine
JPH04202124A (ja) * 1990-11-29 1992-07-22 Fuji Kagaku Kogyo Kk 噴霧乾燥造粒法による薬物放出の制御された製剤の製造法
WO1992013452A1 (fr) * 1991-02-04 1992-08-20 Young James W Procedes d'utilisation et compositions de r(-) fluoxetine
CA2102507A1 (fr) * 1991-05-07 1992-11-08 Judith P. Kitchell Systeme controle de liberation prolongee d'un produit pour le sevrage du tabac
AU668386B2 (en) * 1992-03-25 1996-05-02 Depomed Systems, Incorporated Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
US5518730A (en) * 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
JPH06293633A (ja) * 1993-04-05 1994-10-21 Shin Etsu Chem Co Ltd 水性腸溶性エマルジョンの製造方法
US5362886A (en) 1993-10-12 1994-11-08 Eli Lilly And Company Asymmetric synthesis
DK0726761T3 (da) * 1993-11-03 2001-06-18 Isomed Inc Mikropartikulære farmaceutiske præparater på micel-form
CA2134038C (fr) * 1994-06-16 1997-06-03 David Taiwai Wong Potentialisation des effets de medicaments
US5508276A (en) * 1994-07-18 1996-04-16 Eli Lilly And Company Duloxetine enteric pellets
ES2082723B1 (es) * 1994-07-20 1996-10-01 Lilly Sa Formulacion farmaceutica de fluoxetina en forma dispersable.
JPH08109126A (ja) * 1994-10-07 1996-04-30 Amano Pharmaceut Co Ltd 耐衝撃性腸溶性顆粒剤およびこれを含有する錠剤
JPH08245423A (ja) * 1995-03-06 1996-09-24 Shionogi & Co Ltd 水系腸溶性コーティング液
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation

Also Published As

Publication number Publication date
DE19823940A1 (de) 1998-12-03
LT98058A (en) 1998-10-26
CN1212834C (zh) 2005-08-03
FI119971B (fi) 2009-05-29
NL1009259C2 (nl) 1998-12-01
AT408068B (de) 2001-08-27
RS49827B (sr) 2008-08-07
FR2763846B1 (fr) 2001-05-18
CZ114398A3 (cs) 1998-12-16
ES2161574A1 (es) 2001-12-01
AR011728A1 (es) 2000-08-30
GB2325623B (en) 1999-04-14
SI9800128A (sl) 1999-02-28
PT102152A (pt) 1998-12-31
DK176776B1 (da) 2009-08-10
RO120043B1 (ro) 2005-08-30
IE980284A1 (en) 2000-07-12
CO4940407A1 (es) 2000-07-24
PL192293B1 (pl) 2006-09-29
CA2234826A1 (fr) 1998-11-29
JPH10330253A (ja) 1998-12-15
SE9801336D0 (sv) 1998-04-17
UA48193C2 (uk) 2002-08-15
SE9801336L (sv) 1998-11-30
CA2234826C (fr) 2000-12-19
USRE39030E1 (en) 2006-03-21
SI9800128B (sl) 2000-04-30
PT102152B (pt) 2000-09-29
LV12176A (lv) 1998-12-20
YU16598A (en) 1999-11-22
HUP9800882A3 (en) 2000-07-28
ATA93198A (de) 2001-01-15
US5985322A (en) 1999-11-16
PE75399A1 (es) 1999-08-17
NO982197L (no) 1998-11-30
DE19823940B4 (de) 2010-04-29
FI980846L (fi) 1998-11-30
ES2161574B1 (es) 2002-06-16
NO317743B1 (no) 2004-12-13
GB2325623A (en) 1998-12-02
FI980846A0 (fi) 1998-04-16
CZ290582B6 (cs) 2002-08-14
HUP9800882A2 (hu) 2000-03-28
GB9807939D0 (en) 1998-06-10
CN1200924A (zh) 1998-12-09
TR199800937A3 (tr) 1999-10-21
LT4477B (lt) 1999-03-25
CN1161109C (zh) 2004-08-11
CN1285189A (zh) 2001-02-28
KR19980086622A (ko) 1998-12-05
NO982197D0 (no) 1998-05-14
TWI239838B (en) 2005-09-21
BE1011925A3 (fr) 2000-03-07
JP3210288B2 (ja) 2001-09-17
RU2164405C2 (ru) 2001-03-27
HK1034902A1 (en) 2001-11-09
LU90245A1 (fr) 1998-11-30
GR980100188A (el) 1999-01-29
HU9800882D0 (en) 1998-05-28
AU6904898A (en) 1998-12-03
PL326134A1 (en) 1998-12-07
ITMI980908A1 (it) 1999-10-28
SE522914C2 (sv) 2004-03-16
FR2763846A1 (fr) 1998-12-04
IL124073A (en) 2002-02-10
SG72805A1 (en) 2000-05-23
NZ330192A (en) 1999-08-30
CH693018A5 (de) 2003-01-31
MY118139A (en) 2004-09-30
TR199800937A2 (xx) 1999-10-21
BR9801989A (pt) 2000-02-08
KR100549473B1 (ko) 2006-03-23
ID20343A (id) 1998-12-03
LV12176B (lv) 1999-03-20
AU726690B2 (en) 2000-11-16
SV1998000052A (es) 1999-03-16
US5910319A (en) 1999-06-08
ZA983173B (en) 1999-10-15

Similar Documents

Publication Publication Date Title
LU90245B1 (fr) Pilules de fluox-tine ent-riques
MX208461B (es) Polisacaridos de termofraguado
DE69820407D1 (de) Blisterpackung
FI3988U1 (fi) Kuplapakkaus
DE69814538D1 (de) Verpackung
DE69802434D1 (de) Sprühkappe
DE69827636D1 (de) Blutverdünnungsreagenz
ATA111897A (de) Kimme
ID24444A (id) GEN dtsR PEKA-TEMPERATUR
ATA112597A (de) Snowboard - bindung
FR2772264B1 (fr) Pilulier
FR2770103B1 (fr) Bigoudi perfectionne
DE69721214D1 (de) Blisterverpackung
PT9429T (pt) Gaita de foles
SE9703527D0 (sv) Manipulator
KR970058612U (ko) 스터디 캡슐
PT9496T (pt) Enfuste aperfeicoado
BR7700565U (pt) Overlap
FI3363U1 (fi) Pakkaus
FI3532U1 (fi) Pakkaus
FI2905U1 (fi) Pakkaus
UA1687S (uk) Упаковка
SE9702835D0 (sv) Förpackning
DK15497A (da) Emballering
FI3092U1 (fi) Lompakko matkapuhelinkotelo